NeuroPace Inc invites ASSFN attendees to explore RNS System for adults with refractory seizures

NeuroPace Inc invites ASSFN attendees to explore RNS System for adults with refractory seizures
NeuroPace Inc at ASSFN event

NeuroPace Inc is engaging with attendees at ASSFN, encouraging visitors to stop by Booth 107 to connect with its clinical team and learn more about the RNS System for drug resistant focal epilepsy.

The RNS System is designed as an adjunctive therapy option for adults living with refractory, partial onset seizures. The company emphasizes direct interaction at the event as an opportunity for clinicians and healthcare decision makers to gain deeper insights into the system's clinical applications. Details regarding product use and indications remain available at the venue and through official channels.

NeuroPace previously presented early Nautilus study results and device feasibility for LGS patients at an ASSFN breakfast symposium with leading clinicians, according to company disclosures. The firm has also hosted an exclusive networking dinner for ASSFN fellows focused on neuromodulation practice growth after fellowship, as detailed in prior communications. These activities mark continued engagement with the professional community at ASSFN events.

This material may contain third-party opinions, none of the data and information on this webpage constitutes investment advice according to our Disclaimer. While we adhere to strict Editorial Integrity, this post may contain references to products from our partners.
Weekly Top Bonuses
up to $2,500
deposit bonus for all clients
CLAIM BONUS
Your capital is at risk.